TScan Therapeutics, Inc. · NASDAQ:TCRX

TScan Therapeutics, Inc. shareholders

As of Sep 30, 2026, 49 institutions reported holding TScan Therapeutics, Inc., 51.6% of its shares. Largest: Lynx1 Capital Management LP, Bvf Inc and Boothbay Fund Management, LLC. New holders, exits, insiders and big stakes, each with its filing.

HolderShares% of TScan Therapeutics, Inc.ChangeFiled
Lynx1 Capital Management LP8.02M12.6%no changeNov 16, 2026
Bvf Inc5.56M8.8%no changeNov 16, 2026
Boothbay Fund Management, LLC3.4M5.4%+2.63MNov 16, 2026
Vanguard2.89M4.5%+350KNov 13, 2026
Baker Bros. Advisors LP2.78M4.4%no changeNov 16, 2026
Acadian Asset Management LLC1.69M2.7%+387KNov 9, 2026
Two Sigma1.66M2.6%−291KNov 16, 2026
Deer Management Co. LLC1.25M2.0%no changeNov 16, 2026
Renaissance Technologies1.21M1.9%−119KNov 12, 2026
DC Funds, LP630K0.99%no changeNov 13, 2026

TScan Therapeutics, Inc. insider trades